Karuna Therapeutics
Overview
Karuna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies to address neuropsychiatric disorders. Their lead program, KarXT, is aimed at treating schizophrenia with the potential to revolutionize the way the condition is managed.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Karuna Therapeutics in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Karuna Therapeutics?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.